Latest news
Access to TCRTs in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives - OncodailyOncodaily · Wed, 05 Aug 2026 20:52:31 GMTPhysician Views Results: Latigo's LTG-001 makes strong first impression, but Journavx verdict stays open - FirstWord PharmaFirstWord Pharma · Tue, 28 Jul 2026 02:15:14 GMT